Raymond J. Henley Iii

Array ( [id] => 3838154 [patent_doc_number] => 05846963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome' [patent_app_type] => 1 [patent_app_number] => 8/516540 [patent_app_country] => US [patent_app_date] => 1995-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 12952 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846963.pdf [firstpage_image] =>[orig_patent_app_number] => 516540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3654446 [patent_doc_number] => 05626884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Treatment of sickle cell disease' [patent_app_type] => 1 [patent_app_number] => 8/516737 [patent_app_country] => US [patent_app_date] => 1995-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2837 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/626/05626884.pdf [firstpage_image] =>[orig_patent_app_number] => 516737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3628076 [patent_doc_number] => 05686407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Hepatocyte growth factor to treat glaucoma' [patent_app_type] => 1 [patent_app_number] => 8/515663 [patent_app_country] => US [patent_app_date] => 1995-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1466 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686407.pdf [firstpage_image] =>[orig_patent_app_number] => 515663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626308 [patent_doc_number] => 05621003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Maillard reaction inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/515330 [patent_app_country] => US [patent_app_date] => 1995-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3296 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621003.pdf [firstpage_image] =>[orig_patent_app_number] => 515330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650031 [patent_doc_number] => 05605902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => '5-HT.sub.2 receptor antagonist compositions useful in treating venous conditions' [patent_app_type] => 1 [patent_app_number] => 8/512235 [patent_app_country] => US [patent_app_date] => 1995-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 6 [patent_no_of_words] => 4260 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605902.pdf [firstpage_image] =>[orig_patent_app_number] => 512235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886106 [patent_doc_number] => 05776920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Method for treatment of psoriasis' [patent_app_type] => 1 [patent_app_number] => 8/510389 [patent_app_country] => US [patent_app_date] => 1995-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2345 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776920.pdf [firstpage_image] =>[orig_patent_app_number] => 510389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3557528 [patent_doc_number] => 05502055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-26 [patent_title] => 'Treatment of endotoxic shock with putrescine' [patent_app_type] => 1 [patent_app_number] => 8/510582 [patent_app_country] => US [patent_app_date] => 1995-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 771 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/502/05502055.pdf [firstpage_image] =>[orig_patent_app_number] => 510582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3887512 [patent_doc_number] => 05714511 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs' [patent_app_type] => 1 [patent_app_number] => 8/509558 [patent_app_country] => US [patent_app_date] => 1995-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 9433 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714511.pdf [firstpage_image] =>[orig_patent_app_number] => 509558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692063 [patent_doc_number] => 05618564 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Composition for the treatment of helicobacter pylori infection' [patent_app_type] => 1 [patent_app_number] => 8/508321 [patent_app_country] => US [patent_app_date] => 1995-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3814 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618564.pdf [firstpage_image] =>[orig_patent_app_number] => 508321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688334 [patent_doc_number] => 05643907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of CNS disorders' [patent_app_type] => 1 [patent_app_number] => 8/495428 [patent_app_country] => US [patent_app_date] => 1995-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4348 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643907.pdf [firstpage_image] =>[orig_patent_app_number] => 495428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3616340 [patent_doc_number] => 05614198 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Bowman-Birk Inhibitor compositions for treatment of inflammatory disease' [patent_app_type] => 1 [patent_app_number] => 8/507044 [patent_app_country] => US [patent_app_date] => 1995-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7336 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614198.pdf [firstpage_image] =>[orig_patent_app_number] => 507044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647903 [patent_doc_number] => 05629284 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Method for treating retinal diseases' [patent_app_type] => 1 [patent_app_number] => 8/505907 [patent_app_country] => US [patent_app_date] => 1995-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3109 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629284.pdf [firstpage_image] =>[orig_patent_app_number] => 505907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693238 [patent_doc_number] => 05595763 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Tungsten (VI) compositions for the oral treatment of diabetes mellitus' [patent_app_type] => 1 [patent_app_number] => 8/504020 [patent_app_country] => US [patent_app_date] => 1995-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4753 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595763.pdf [firstpage_image] =>[orig_patent_app_number] => 504020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3649597 [patent_doc_number] => 05637768 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Process for making (2S,5S)-5-fluoromethylornithine' [patent_app_type] => 1 [patent_app_number] => 8/491968 [patent_app_country] => US [patent_app_date] => 1995-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10278 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637768.pdf [firstpage_image] =>[orig_patent_app_number] => 491968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665992 [patent_doc_number] => 05597844 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Cimetidine granules coated with a partially hydrogenated vegetable oil' [patent_app_type] => 1 [patent_app_number] => 8/446708 [patent_app_country] => US [patent_app_date] => 1995-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2790 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597844.pdf [firstpage_image] =>[orig_patent_app_number] => 446708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620030 [patent_doc_number] => 05607674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Use of Tarchonanthus camphoratus for repelling insects and alleviating edema, congestion and irritation of the skin' [patent_app_type] => 1 [patent_app_number] => 8/428175 [patent_app_country] => US [patent_app_date] => 1995-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2857 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607674.pdf [firstpage_image] =>[orig_patent_app_number] => 428175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658974 [patent_doc_number] => 05591736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Method of retarding the progression of chronic renal failure' [patent_app_type] => 1 [patent_app_number] => 8/497958 [patent_app_country] => US [patent_app_date] => 1995-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2960 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591736.pdf [firstpage_image] =>[orig_patent_app_number] => 497958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661144 [patent_doc_number] => 05648351 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Use of macrolides for the treatment of cerebral ischemia' [patent_app_type] => 1 [patent_app_number] => 8/464815 [patent_app_country] => US [patent_app_date] => 1995-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3637 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648351.pdf [firstpage_image] =>[orig_patent_app_number] => 464815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3878171 [patent_doc_number] => 05728692 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Methotrexate derivative' [patent_app_type] => 1 [patent_app_number] => 8/454290 [patent_app_country] => US [patent_app_date] => 1995-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2591 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728692.pdf [firstpage_image] =>[orig_patent_app_number] => 454290 [rel_patent_id] =>[rel_patent_doc_number] =>)